A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases

EMBO Journal

Volumn 18, Issue 2, 1999, Pages 363-374

  Meyer, Marlene ^g   Clauss, Matthias ^a   Lepple Wienhues, Albrecht ^b   Waltenberger, Johannes ^c   Augustin, Hellmut G ^d   Ziche, Marina ^e   Lanz, Christa ^g   Büttner, Mathias ^f   Rziha, Hanns Joachim ^f   Dehio, Christoph ^g  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e UNIVERSITY OF FLORENCE   (Italy)

^f FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^g MAX PLANCK INST FÜR BIOLOGIE   (Germany)

Author keywords

Angiogenesis; Flt 1; KDR; Orf virus; VEGF

Indexed keywords

CYSTEINE; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; THROMBOPLASTIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL PROLIFERATION; CHEMOTAXIS; ENDOTHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POXVIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THERMOSTABILITY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; COS CELLS; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ESCHERICHIA COLI; GENE EXPRESSION; GENES, VIRAL; HUMANS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; ORF VIRUS; PROTO-ONCOGENE PROTEINS; RABBITS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; THROMBOPLASTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS; VIRAL PROTEINS;

ANIMALIA; DNA VIRUSES; ESCHERICHIA COLI; MAMMALIA; ORF VIRUS; PARAPOXVIRUS; POXVIRIDAE;

EID: 0033556287     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.2.363     Document Type: Article

References (64)

1. Achen, M.G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A.F., Alitalo, K. and Stacker, S.A. (1998) Vascular cndothclial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl Acad Sci. USA, 95, 548-553.
2. Adriana, A., Benelli, R., Presta, M., Rusnati, M., Ziche, M., Rubartelli, A., Paglialunga, G., Bussolino, F. and Noonan, D. (1996a) HIV-tat protein is a heparin-hinding angiogenic factor. Oncogene, 12, 289-297.
3. Adriana, A. et al. (1996b) The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Med., 2, 1371-1375.
4. Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K. and Isner, J.M. (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation, 97, 1114-1123.
5. Buonaguro, L., Buonaguro, F.M., Giraldo, G. and Ensoli, B. (1994) The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol., 68, 2677-2682.
6. Carmeliet, P. et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439.
7. Clauss, M. et al. (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J. Exp. Med., 172, 1535-1545.
8. Clauss, M., Grell, M., Fangmann, C., Fiers, W., Scheurich, P. and Risau, W. (1996a) Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors. FEBS Lett., 390, 334-338.
9. Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J. and Risau, W. (1996b) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem., 271, 17629-17634.
10. Corpet, F. (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res., 16, 10881-10890.
11. Cottone, R., Büttner, M., Bauer, B., Henkel, M., Hettich, E. and Rziha, H.-J. (1998) Analysis of genomic rearragement and subsequent gene deletion of the attenuated Orf virus strain D1701. Virus Res., 56, 53-67.
12. de Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N. and Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991.
13. Dehio, C., Meyer, M., Berger, J., Schwarz, H. and Lanz, C. (1997) Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique cellular structure, the invasome. J. Cell Sci., 110, 2141-2154.
14. Ferrara, N. and Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocrinol. Rev., 18, 4-25.
15. Ferrara, N., Houck, K., Jakeman, L. and Leung, D.W. (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev., 13, 18-32.
16. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442.
17. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
18. Folkman, J. (1998) Therapeutic angiogenesis in ischemic limbs. Circulation, 97, 1108-1110.
19. Fong, G.H., Rossant, J., Gertsenstein, M. and Breitman, M.L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376, 66-70.
20. Groves, R.W., Wilson-Jones, E. and MacDonald, D.M. (1991) Human orf and milkers' nodule: a clinicopathologic study. J. Am. Acad. Dermatol., 25, 706-711.
21. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
22. Haig, D.M. and Mercer, A.A. (1998) Orf. Vet. Res., 29, 311-326.
23. Heldin, C.H. (1995) Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
24. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. and Shibuya, M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl Acad. Sci. USA, 95, 9349-9354.
25. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15, 290-298 [published erratum appeared 1996 in EMBO J., 15, 1751]
26. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N. and Alitalo, K. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J., 16, 3898-3911.
27. Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H. and Ferrara (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol Chem., 271, 5638-5646.
28. Klagsbrun, M. and D'Amore, P.A. (1996) Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev., 7, 259-270.
29. Korff, T. and Augustin, H.G. (1998) Integration of endothelial cells in multicellular spheroides prevents apoptosis and induces differentiation. J. Cell Biol., in press.
30. Kroll, J. and Waltenberger, J. (1997) The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem., 272, 32521-32527.
31. Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V. and Alitalo, K. (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development, 122, 3829-3837.
32. Lee, J., Gray, A., Yuan, J., Luoh, S.M., Avraham, H. and Wood, W.I. (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl Acad. Sci. USA, 93, 1988-1992.
33. Lyttle, D.J., Fraser, K.M., Fleming, S.B., Mercer, A.A. and Robinson, A.J. (1994) Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J. Virol., 68, 84-92.
34. Mack, C.A. et al. (1998) Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg., 115, 168-176.
35. Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. and Persico, M.G. (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl Acad. Sci. USA, 88, 9267-9271.
36. McDonald, N.Q. and Hendrickson, W.A. (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell, 73, 421-424.
37. Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C. and de Vos, A.M. (1997) Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proc. Natl Acad. Sci. USA, 94, 7192-7197.
38. Myoken, Y., Kayada, Y., Okamoto, T., Kan, M., Sato, G.H. and Sato, J.D. (1991) Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl Acad Sci. USA, 88, 5819-5823.
39. Nehls, V. and Drenckhahn, D. (1995) A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res., 50, 311-322.
40. Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K. and Eriksson, U. (1996) Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem., 271, 19310-19317.
41. Olofsson, B. et al. (1998) Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl Acad. Sci. USA, 95, 11709-11714.
42. Park, J.E., Chen, H.H., Winer, J., Houck, K.A. and Ferrara, N. (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem., 269, 25646-25654.
43. Plouet, J. and Moukadiri, H. (1990) Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J. Biol. Chem., 265, 22071-22074.
44. Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E. and Neufeld, G. (1997) VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem., 272, 7151-7158.
45. Quinn, T.P., Peters, K.G., de Vries, C., Ferrara, N. and Williams, L.T. (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA, 90, 7533-7537.
46. Risau, W. (1997) Mechanisms of angiogenesis. Nature, 386, 671-674.
47. Risau, W. and Flamme, I. (1995) Vasculogenesis. Annu. Rev. Cell Dev. Biol., 11, 73-91.
48. Risau, W. and Lemmon, V. (1988) Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev. Biol., 125, 441-450.
49. Roeckl, W., Hecht, D., Sztajer, H., Waltenberger, J., Yayon, A. and Weich, H.A. (1998) Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp. Cell Res., 241, 161-170.
50. Rziha, H.-J., Henkel, M., Rosita, C., Meyer, M., Dehio, C. and Büttner, M. (1998) Parapoxviruses: Potential alternative vectors for directing the immune response in permissive and non-permissive hosts. J. Biotechnol., in press.
51. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual (2nd edition). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
52. Schenk, P.M., Baumann, S., Mattes, R. and Steinbiss, H.H. (1995) Improved high-level expression system for eukaryotic genes in Escherichia coli using T7 RNA polymerase and rare ArgtRNAs. Biotechniques, 19, 196-198.
53. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983-985.
54. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G. and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92, 735-745.
55. Terman, B.I., Dougher-Vermazen, M., Carrion, M.E., Dimitrov, D., Armellino, D.C., Gospodarowicz, D. and Bohlen, P. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187, 1579-1586.
56. Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 22, 4673-4680.
57. Waltenberger, J. (1997) Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation, 96, 4083-4094.
58. Waltenberger, J. et al. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269, 26988-26995.
59. Waltenberger, J., Mayr, U., Pentz, S. and Hombach, V. (1996) Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation, 94, 1647-1654.
60. Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A. and de Vos, A.M. (1997) Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell, 28, 695-704.
61. Weissman, J.D., Brown, J.A., Howcroft, T.K., Hwang, J., Chawla, A., Roche, P.A., Schiltz, L., Nakatani, Y. and Singer, D.S. (1998) HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class 1 genes. Proc. Natl Acad. Sci. USA, 95, 11601-11606.
62. Ziche, M., Alessandri, G. and Gullino, P.M. (1989) Gangliosides promote the angiogenic response. Lab. Invest., 61, 629-634.
63. Ziche, M., Morbidelli, L., Masini, E., Amerini, S., Granger, H.J., Maggi, C.A., Geppetti, P. and Ledda, F. (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94, 2036-2044.
64. Ziche, M. et al. (1997) Placenta growth factor-1 is chemotactic, mitogenic and angiogenic. Lab. Invest., 76, 517-531.